Skip to main content
EN
Caution:
At present, there are occasional discrepancies in the display of intellectual property rights holders and their representatives. We are working on a solution.
Patent Search
Details
see.ip - Details for MODULATOREN VON HÄMOGLOBIN ZUR BEHANDLUNG VON SICHELZELLENANÄMIE
Details for 2019787545
Up to date per 10.06.2026
Actions
Copy link to European Patent
Download Registration Print
Details
Details for 2019787545
Title / Product Name
MODULATOREN VON HÄMOGLOBIN ZUR BEHANDLUNG VON SICHELZELLENANÄMIE
Status
Deleted
Protection Type
European Patent
(AT-) Application Number
2019787545
EP Publication Number
3860975
E-Number
1622347
Language
EN
PCT Number
US19053862
Publication Date
11.08.2021 A
18.10.2023 B1
Registration Date
18.10.2023
AT Publication Date
15.11.2023
Application Date
30.09.2019
Registration Number
-
Priorities
01.10.2018
US
201862739757 P
20.03.2019
US
201962821311 P
IPC
C07D 207/08 20060101AFI20230428BHEP
Maximum Duration of Protection
30.09.2039
Owner
Global Blood Therapeutics, Inc.
181 Oyster Point Blvd.
South San Francisco, CA 94080
US
Representative
No representatives present
Inventor
METCALF, Brian W.
c/o Global Blood Therapeutics, Inc. 181 Oyster Point Boulevard
South San Francisco, California 94080
US
LI, Zhe
c/o Global Blood Therapeutics, Inc. 181 Oyster Point Boulevard
South San Francisco, California 94080
US
XU, Qing
c/o Global Blood Therapeutics, Inc. 181 Oyster Point Boulevard
South San Francisco, California 94080
US
DUFU, Kobina N.
c/o Global Blood Therapeutics, Inc. 181 Oyster Point Boulevard
South San Francisco, California 94080
US
PARTRIDGE, James
c/o Global Blood Therapeutics, Inc. 181 Oyster Point Boulevard
South San Francisco, California 94080
US
SHAM, Hing
c/o Global Blood Therapeutics, Inc. 181 Oyster Point Boulevard
South San Francisco, California 94080
US
YU, Ming
c/o Global Blood Therapeutics, Inc. 181 Oyster Point Boulevard
South San Francisco, California 94080
US